Our research into drug discovery and development
Cancer Research UK is committed to developing better, more targeted cancer treatments with fewer side effects.
In recent years, scientists have learnt a great deal about how faulty genes and proteins contribute to cancer development. This has opened up new opportunities for converting key lab discoveries into exciting new approaches to cancer treatment.
Cancer Research UK is at the forefront of this ‘bench-to-bedside’ medicine or ‘translational research’. Many of our researchers are internationally renowned for their expertise in discovering new cancer drugs and taking these forward into early-stage clinical trials.
Below are some of the highlights of our drug development work.
Bowel cancer
Prof Chris Paraskeva
Colorectal Tumour Biology Research Group
University of Bristol, Bristol
Preventing and treating bowel cancer
Kidney cancer
Prof Peter Selby
Section of Oncology and Clinical Research
Leeds Institute of Molecular Medicine, Leeds
Developing and testing new ways to treat cancer
No specific cancer type
Prof Richard Begent
Cancer Research UK Targeting and Imaging Group, Department of Oncology
UCL Cancer Institute, London
Developing and testing new treatments for cancer
Prof Caroline Dive
Clinical and Experimental Pharmacology Group
Paterson Institute for Cancer Research, Manchester
Developing new cancer treatments
Prof Gavin Halbert
Cancer Research UK Formulation Unit
University of Strathclyde, Glasgow
Turning lab discoveries into cancer drugs
Prof Bass Hassan
Department of Medical Oncology
Weatherall Institute of Molecular Medicine, Oxford
Blocking growth signals to beat cancer
Prof Steve Jackson
The Wellcome Trust/Cancer Research UK Gurdon Institute of Cancer and Developmental Biology
University of Cambridge, Cambridge
Understanding DNA repair
Prof Nicol Keith
Telomerase Therapeutics
Beatson Laboratories, Glasgow
Developing new anti-cancer therapies
Prof Herbie Newell
Northern Institute for Cancer Research
University of Newcastle, Newcastle Upon Tyne
Developing new cancer treatments
Professor David Thurston
The London School of Pharmacy
University of London, London
Discovering new cancer drugs
Prof Paul Workman
Cancer Research UK Centre for Cancer Therapeutics
The Institute of Cancer Research, Sutton
Developing targeted cancer treatments
Ovarian cancer
Prof Gordon Jayson
Translational Angiogenesis Laboratory
Christie Hospital NHS Trust, Manchester
New cancer treatments that block blood vessel growth
Prof Stan Kaye
Section of Medicine
The Institute of Cancer Research and the Royal Marsden Hospital, Sutton
Developing new cancer treatments
Prostate cancer
Prof Gareth Williams
Cancer Research UK Chromosomal Replication Research Group
Wolfson Institute for Biomedical Research, University College London, London
Increase text
Decrease text
Print this page
